Real-World Effectiveness and Safety of Imeglimin in Type 2 Diabetes: Prospective Multi-Center Study in Bangladesh

20260 citationsJournal Articlegold Open Access

Authors

Imeglimin demonstrated substantial glycemic improvements and favorable safety in real-world Bangladeshi patients with poor glycemic control.

No poverty

Published in: Diabetes Metabolic Syndrome and Obesity

Volume Volume 19, pp. 1-16

Field-Weighted Citation Impact: 0.00